RE: FOR PLOVIEPalnic,
I strongly disagree. The company would not spin off the company, then turn around 6-12 months later and do a secondary.
1. During the conference call of the spin off, they stated they would have enough capital for 3 years in order to get their products on the market.
2. They would not do a secondary at these prices. They may however sell a stake to a large pharm company.
3. I think its ridiculous to think a secondary is coming. However, you would be right that they would have no credibility if that does happen.